| Trial ID: | L2742 |
| Source ID: | NCT01890629
|
| Associated Drug: |
Gemigliptin + Metformin / Sitagliptin + Metformin / Glimepiride + Metformin
|
| Title: |
Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)
|
| Acronym: |
STABLE
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Gemigliptin + Metformin / Sitagliptin + Metformin / Glimepiride + Metformin
|
| Outcome Measures: |
Primary: Mean Amplitude Glycemic Excursion, Change of MAGE at Week 12 from baseline | Secondary: Glucagon, Change of Glucagon at Week 12 from baseline|Active GLP-1, Change of Active GLP-1 at Week 12 from baseline|CRP, Change of CRP at Week 12 from baseline|Nitrotyrosine, Change of nitrotyrosine at Week 12 from baseline|Glycated albumin, Change of glycated albumin at Week 4 from baseline|Fructosamine, Change of fructosamine at Week 4 from baseline|Glucose Standard Deviation in CGMS data, Change of Glucose SD at Week 12 from baseline
|
| Sponsor/Collaborators: |
Sponsor: LG Life Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
69
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-05
|
| Completion Date: |
2014-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-13
|
| Locations: |
Severance hospital, Seoul, 120-752, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01890629
|
